Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Lorber

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Transplantation Proceedings|May 14, 2003
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantationR N Formica, K M Lorber, A L Friedman, et al.
Transplantation Proceedings|March 26, 2004
The evolving experience using everolimus in clinical transplantationR N Formica, K M Lorber, A L Friedman, et al.
Transplantation|October 27, 1997
Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapyI A Darenkov, M A Marcarelli, G P Basadonna, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Transplantation Proceedings|May 14, 2003
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantationR N Formica, K M Lorber, A L Friedman, et al.
Transplantation Proceedings|March 26, 2004
The evolving experience using everolimus in clinical transplantationR N Formica, K M Lorber, A L Friedman, et al.
Transplantation|October 27, 1997
Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapyI A Darenkov, M A Marcarelli, G P Basadonna, et al.
Pageof 1